SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 110 filers reported holding SUTRO BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is 1.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $57 | -72.9% | 12,250 | -73.1% | 0.00% | -80.0% |
Q1 2023 | $210 | -99.9% | 45,540 | +105.2% | 0.01% | -16.7% |
Q1 2022 | $182,000 | -59.6% | 22,189 | -26.7% | 0.01% | -78.6% |
Q4 2021 | $450,000 | -30.2% | 30,262 | -11.4% | 0.06% | -34.9% |
Q3 2021 | $645,000 | +53.9% | 34,152 | +51.5% | 0.09% | -39.0% |
Q2 2021 | $419,000 | -59.8% | 22,550 | -50.8% | 0.14% | -57.7% |
Q1 2021 | $1,042,000 | -25.3% | 45,790 | -28.7% | 0.33% | -16.3% |
Q4 2020 | $1,395,000 | – | 64,250 | – | 0.40% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SV Health Investors, LLC | 1,824,542 | $27,149,000 | 17.55% |
Samsara BioCapital, LLC | 1,675,579 | $24,933,000 | 4.84% |
AJU IB Investment Co., Ltd. | 175,000 | $2,604,000 | 3.63% |
First Light Asset Management, LLC | 2,246,588 | $33,429,000 | 2.39% |
Opaleye Management Inc. | 680,000 | $10,118,000 | 2.15% |
FRAZIER MANAGEMENT LLC | 1,776,479 | $26,434,000 | 2.04% |
Connective Portfolio Management, LLC | 35,000 | $527,000 | 0.93% |
Parkman Healthcare Partners LLC | 221,219 | $3,292,000 | 0.73% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 2,437,795 | $36,274,000 | 0.70% |
Eventide Asset Management | 2,708,975 | $40,310,000 | 0.52% |